{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:16:46Z","timestamp":1784074606704,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.leukres.2023.107432","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T14:55:09Z","timestamp":1702652109000},"page":"107432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["VEXAS syndrome in a patient with DDX41 germline predisposition syndrome"],"prefix":"10.1016","volume":"136","author":[{"given":"Yael","family":"Kusne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Badar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.leukres.2023.107432_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2023.107432_bib2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.leukres.2023.107432_bib3","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2019000909","article-title":"Germline DDX41 mutations define a significant entity within adult MDS\/AML patients","volume":"134","author":"Sebert","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2023.107432_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood.2022018221","article-title":"Germ line DDX41 mutations define a unique subtype of myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2023.107432_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1182\/blood.2021015135","article-title":"The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms","volume":"140","author":"Li","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107432_bib6","article-title":"Next-generation sequencing of DDX41 in myeloid neoplasms leads to increased detection of germline alterations","volume":"10","author":"Bannon","year":"2020","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2023.107432_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/bloodadvances.2021005738","article-title":"Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms","volume":"6","author":"Alkhateeb","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2023.107432_bib8","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2023010045","article-title":"Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variants","author":"Homan","year":"2023","journal-title":"Blood Adv."},{"issue":"27","key":"10.1016\/j.leukres.2023.107432_bib9","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.leukres.2023.107432_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020344","article-title":"Current understanding of DDX41 mutations in myeloid neoplasms","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.leukres.2023.107432_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/hematology.2020006910","article-title":"Identifying potential germline variants from sequencing hematopoietic malignancies","volume":"2020","author":"Kraft","year":"2020","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"16","key":"10.1016\/j.leukres.2023.107432_bib12","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.leukres.2023.107432_bib13","first-page":"244","article-title":"Spectrum of clonal hematopoiesis in VEXAS syndrome","volume":"142","author":"Gutierrez-Rodrigues","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2023.107432_bib14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1182\/bloodadvances.2021004749","article-title":"Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience","volume":"6","author":"Diarra","year":"2022","journal-title":"Blood Adv."},{"issue":"7","key":"10.1016\/j.leukres.2023.107432_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.2021015328","article-title":"Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study","volume":"140","author":"Duployez","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2023.107432_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:04:53Z","timestamp":1758935093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623006975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":16,"alternative-id":["S0145212623006975"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107432","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VEXAS syndrome in a patient with DDX41 germline predisposition syndrome","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107432"}}